BioCryst Pharmaceuticals, Inc. is in its Mercury mahadasha (13 Jan 2011 to 13 Jan 2028), Saturn antardasha (5 May 2025 to 13 Jan 2028) and Sun pratyantar (3 Oct 2026 to 21 Nov 2026).
Next: pratyantar Moon from 21 Nov 2026; antardasha Ketu from 13 Jan 2028; mahadasha Ketu from 13 Jan 2028.
| Planet | Sign | Degree | House | Nakshatra |
|---|---|---|---|---|
| Sun | Kumbha (Aquarius) | 19°01′ | 11th | Shatabhisha 4 |
| Moon | Vrishchika (Scorpio) | 4°50′ | 8th | Anuradha 1 |
| Mars | Kumbha (Aquarius) | 3°12′ | 11th | Dhanishta 3 |
| Mercury (R) | Makara (Capricorn) | 29°00′ | 10th | Dhanishta 2 |
| Jupiter (R) | Tula (Libra) | 20°52′ | 7th | Vishakha 1 |
| Venus | Meena (Pisces) | 0°00′ | 12th | Purva Bhadrapada 4 |
| Saturn | Kumbha (Aquarius) | 10°16′ | 11th | Shatabhisha 2 |
| Rahu | Vrishchika (Scorpio) | 4°04′ | 8th | Anuradha 1 |
| Ketu | Vrishabha (Taurus) | 4°04′ | 2nd | Krittika 3 |
Whole-sign houses counted from the lagna, True Chitra ayanamsa, Vimshottari dashas from the Moon's nakshatra. How the chart is cast.
The full chart adds the D1, D9 and D10 charts to explore, every antardasha and pratyantar, how BCRX moved in each period against the S&P 500, transits, fundamentals and news.